Our portfolio company Oncimmune has announced encouraging interim results of an early detection programme for lung cancer in the UK which first started in 2012. With over 1.5 million deaths in 2012, lung cancer kills more people than any other cancer worldwide, and Oncimmune’s EarlyCDT-Lung blood test may be able to pick up very small early stage lung cancers symptoms which is important in countries where CT screening is simply not possible due to the cost and availability of machines.

Click here for the full press release.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound